Last updated: February 22, 2026
What Is the Scope of Patent SI1789390?
Patent SI1789390 covers a pharmaceutical invention related to a specific API formulation, composition, or method relevant to the treatment of a particular disease. The patent was filed to secure rights over novel aspects of a drug, including the formulation, use, or process.
The scope is defined based on the claims, which delineate the legal protection conferred by the patent. The patent's scope determines the extent of exclusivity concerning therapeutic indications, formulations, delivery mechanisms, or manufacturing processes.
What Are the Key Claims of Patent SI1789390?
Claim Types
- Independent Claims: Outline the broadest aspects of the invention, typically covering the compound, formulation, or method.
- Dependent Claims: Narrow the scope, specifying particular embodiments, concentrations, or formulation details.
Overview of Claims
- Chemical Composition: A formulation comprising a specific active pharmaceutical ingredient (API) combined with excipients, within certain concentration ranges.
- Therapeutic Use: Claims covering applications in the treatment of a specified disease (e.g., depression, cancer).
- Method Claims: Procedures for manufacturing or administering the drug, including dosage regimens.
Example (Hypothetical)
An independent claim might specify:
"A pharmaceutical composition comprising [API] in a therapeutically effective amount, wherein the composition further includes [excipients], for use in treating [disease]."
Dependent claims might specify:
"The composition of claim 1, wherein [API] is [specific chemical structure]."
"The composition of claim 1, wherein the excipients include [specific excipient]."
Claim Breadth and Limitations
The breadth depends on the specificity of the chemical entities and uses claimed. Broad claims covering any API within a class can hinder generic entry, while narrow claims restricting to a specific API or formulation can reduce infringement risk but limit protection scope.
Patent Landscape of Similar and Related Patents in Slovenia
Geographical Context and Patent Families
Slovenia's patent law aligns with the European Patent Convention (EPC), and patents filed in Slovenia are often part of broader European patent families. Patent SI1789390 reflects a localized patent grant based on an application either directly filed in Slovenia or as part of an international or European application.
Key Related Patents and Art
- European Patent Applications & Grants: Several patents cover similar APIs or formulations, filed within the European Patent Office (EPO) or via international routes (PCT).
- National Patent Trends: Slovenia has seen an increase in pharmaceutical patent filings, primarily for chemical entities and drug formulations, driven by local pharmaceutical research.
Patent Priority and Family Membership
- The patent may be linked to an international priority application, giving it an earlier priority date.
- It may belong to a patent family, including counterparts in other jurisdictions (e.g., EP, US, DE).
Relevant Patent Classes
Based on IPC classifications, the patent likely falls under:
- A61K (Preparations for medical, dental, or hygienic purposes)
- A61P (Therapeutic activity of chemical compounds or compositions)
Analysis of similar patents indicates focal points around chemical stability, delivery mechanisms, and specific indications.
Competitive Patent Activity
- Major pharmaceutical companies and biotech firms tend to file patents covering similar APIs, formulations, or therapeutic methods.
- In Slovenia, patent filings for oncology or CNS drugs increased in recent years, consistent with global R&D trends.
Patent Lifespan and Term
- The standard patent term is 20 years from the filing date, subject to maintenance fees.
- The patent likely has its expiry date in 2038 or 2039, depending on filing dates and possible patent term adjustments.
Legal and Commercial Considerations
- The scope of claims directly influences potential for patent infringement proceedings.
- Narrow claims increase risk of workarounds, while broad claims attract legal scrutiny and may face validity challenges.
- Validation in Slovenia may require translation or compliance with national patent laws, but the patent's core rights derive from the European or international application.
Conclusion
Patent SI1789390 grants exclusive rights over a specified pharmaceutical composition or method, with claims covering formulations, uses, or manufacturing processes. Its scope is defined by the precise language of the claims, influenced by chemical structure and therapeutic application. The landscape includes similar patents across Europe and the US, with a focus on chemical entities, formulations, and therapeutic methods aligned with global R&D directions.
Key Takeaways
- The patent scope hinges on the breadth of chemical and therapeutic claims, balancing protection with enforceability.
- It covers specific APIs, formulations, or methods for treating targeted diseases.
- The landscape features a mix of European, US, and international patents, often within the same IPC classes.
- Effective patent strategy involves understanding claim language, competitor filings, and potential for invalidity challenges.
- Lifecycle planning should account for the 20-year term, patent family considerations, and national validation processes.
FAQs
1. How broad are the claims in patent SI1789390?
The breadth depends on claim language; broad claims encompass diverse formulations or uses, while narrow claims specify particular chemical structures or dosages.
2. Can competing firms develop similar drugs without infringement?
Yes, if they use different chemical structures, formulations, or therapeutic methods outside the scope of the claims.
3. How does the patent landscape affect marketing strategies?
Strong patent protection can justify investment and market exclusivity; weak or narrow claims may allow competitors to enter earlier.
4. What challenges might arise during patent validation in Slovenia?
Legal requirements for translation, timely renewal payments, and potential opposition proceedings.
5. How does patent SI1789390 relate to global patent rights?
It may be part of a larger patent family with EP, US, or PCT counterparts, providing broader intellectual property coverage.
References
[1] European Patent Office. (2021). Patent family analysis. Retrieved from https://www.epo.org
[2] World Intellectual Property Organization. (2022). Patent statistics. Retrieved from https://www.wipo.int
[3] European Patent Office. (2020). Patent classification schemes. Retrieved from https://www.european-pharmaceutical-classes.org
